Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G R Dreesman

Showing results (111-120 of 121) with videos related to

Pageof 13
Sort By:
JAMA|November 4, 1983
Posttransfusion hepatitis type AF B Hollinger, N C Khan, P E Oefinger, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1989
Antibody-dependent enhancement of human immunodeficiency virus type 1 (HIV-1) infection in vitro by serum from HIV-1-infected and passively immunized chimpanzeesW E Robinson, D C Montefiori, W M Mitchell, et al.
Laboratory Animal Science|April 1, 1988
Lymphocyte subsets in chimpanzeesJ W Eichberg, M M Montiel, B A Morale, et al.
Cancer Research|February 1, 1976
Studies on herpes simplex virus and cancerJ L Melnick, R J Courtney, K L Powell, et al.
Nature|January 14, 1982
Antibody to hepatitis B surface antigen after a single inoculation of uncoupled synthetic HBsAg peptidesG R Dreesman, Y Sanchez, I Ionescu-Matiu, et al.
Journal of Virology|May 1, 1983
Inhibition of a common human anti-hepatitis B surface antigen idiotype by a cyclic synthetic peptideR C Kennedy, G R Dreesman, J T Sparrow, et al.
The New England Journal of Medicine|August 27, 1981
Herpesvirus-induced antigens in squamous-cell carcinoma in situ of the vulvaR H Kaufman, G R Dreesman, J Burek, et al.
Science (New York, N.Y.)|August 24, 1990
Conserved sequence and structural elements in the HIV-1 principal neutralizing determinantG J LaRosa, J P Davide, K Weinhold, et al.
Science (New York, N.Y.)|February 15, 1991
Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant: corrections and clarificationsG J LaRosa, J P Davide, K Weinhold, et al.
Science (New York, N.Y.)|September 6, 1991
Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant: further clarificationsG J LaRosa, K Weinhold, A T Profy, et al.
Pageof 13

Showing results (111-120 of 121) with videos related to

Sort By:
Pageof 13
JAMA|November 4, 1983
Posttransfusion hepatitis type AF B Hollinger, N C Khan, P E Oefinger, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1989
Antibody-dependent enhancement of human immunodeficiency virus type 1 (HIV-1) infection in vitro by serum from HIV-1-infected and passively immunized chimpanzeesW E Robinson, D C Montefiori, W M Mitchell, et al.
Laboratory Animal Science|April 1, 1988
Lymphocyte subsets in chimpanzeesJ W Eichberg, M M Montiel, B A Morale, et al.
Cancer Research|February 1, 1976
Studies on herpes simplex virus and cancerJ L Melnick, R J Courtney, K L Powell, et al.
Nature|January 14, 1982
Antibody to hepatitis B surface antigen after a single inoculation of uncoupled synthetic HBsAg peptidesG R Dreesman, Y Sanchez, I Ionescu-Matiu, et al.
Journal of Virology|May 1, 1983
Inhibition of a common human anti-hepatitis B surface antigen idiotype by a cyclic synthetic peptideR C Kennedy, G R Dreesman, J T Sparrow, et al.
The New England Journal of Medicine|August 27, 1981
Herpesvirus-induced antigens in squamous-cell carcinoma in situ of the vulvaR H Kaufman, G R Dreesman, J Burek, et al.
Science (New York, N.Y.)|August 24, 1990
Conserved sequence and structural elements in the HIV-1 principal neutralizing determinantG J LaRosa, J P Davide, K Weinhold, et al.
Science (New York, N.Y.)|February 15, 1991
Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant: corrections and clarificationsG J LaRosa, J P Davide, K Weinhold, et al.
Science (New York, N.Y.)|September 6, 1991
Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant: further clarificationsG J LaRosa, K Weinhold, A T Profy, et al.
Pageof 13